From Raw Counts to Biological Insight: Handling TempO-Seq Data Effectively Ayokunmi AkanleJuly 21, 2026
BioSpyder Brings TempO-Seq Technology to Thailand Through New Distribution Agreement Ayokunmi AkanleJuly 6, 2026
BioSpyder Expands Presence in Southeast Asia Through Distribution Partnership with Atlantis Bioscience Ayokunmi AkanleJune 29, 2026
BioSpyder Expands Presence in South Korea Through Distribution Partnership with LAS Ayokunmi AkanleJune 22, 2026
BioSpyder Marks Presence in Japan Through Distribution Agreement with AS-ONE Ayokunmi AkanleJune 17, 2026
BioSpyder’s TempO-Seq Platform Supports FDA’s Expanding New Approach Methodologies Framework for Nonclinical Safety Assessment Ayokunmi AkanleJune 15, 2026
BioSpyder awarded 5-year EPA contract, up to $25 million to perform high throughput genetic toxicology screening. Ayokunmi AkanleNovember 25, 2025
BioSpyder Secures 5-Year TempO-Seq Supply Agreement with Health Canada Ayokunmi AkanleSeptember 15, 2025
BioSpyder attends and exhibits at the International Society for Animal Genetics Conference Ayokunmi AkanleJuly 15, 2025
BioSpyder Advances Single-Cell Genomics with Launch of TempO-LINC Platform Ayokunmi AkanleJanuary 29, 2024
